Objective:To compare the clinical activity, survival and toxicity of IVP and CAP for advanced non small cell cancer(NSCLC)in aged.
目的对比IVP方案与CAP方案治疗老年晚期非小细胞肺癌的临床疗效、生存期及毒副反应。
Objective:To observe the efficacy and toxicity of domestic epirubicin in treatment of non Hodgkin's lymphoma, breast cancer, and non small cell lung cancer.
目的：观察国产表柔比星为主的联合化疗方案治疗非霍奇金淋巴瘤、乳腺癌、非小细胞肺癌的疗效和不良反应。
Objective: to evaluate the clinical efficacy and toxicity of domestic vinorelbine (Gainuo) plus cisplatin in the treatment of advanced non small cell lung cancer.
目的：观察国产去甲长春花碱(盖诺)与顺铂治疗晚期非小细胞肺癌的疗效及毒副反应。
There are two major types: non-small cell lung cancer, which is the most common, and small cell lung cancer, which spreads more quickly.
有两种主要类型：最常见的是“非小细胞肺癌”；另一种是扩展非常迅速的“小细胞肺癌”。
Objective To determine the cut-off value of serum neuron-specific enolase (NSE) level for distinguishing small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
目的通过较大样本血清神经元特异烯醇化酶(nse)的检测，确定鉴别小细胞肺癌(SCLC)与非小细胞肺癌(NSCLC) NSE血清水平临界值。
Objective to investigate the expression of COX-2 and its relation to clinical pathophysiological features and prognosis in non-small cell lung cancer (NSCLC).
目的探讨非小细胞肺癌组织中COX 2的表达情况及其与患者临床病理生理特征和预后的关系。
Objective: To study the expression of KAI1/CD82 in non-small cell lung carcinomas (NSCLC) and explore the mechanism of invasion and metastasis of tumor cell.
目的：探讨KAI1/CD82 基因在非小细胞肺癌（NSCLC）组织中的表达水平及在癌细胞发生侵袭、转移过程中的意义。
Clinical effect of radiotherapy combined with GP regimen chemotherapy in advanced non - small cell lung cancer.
放疗加gp方案化疗治疗中晚期非小细胞肺癌疗效观察。
Objective To investigate the economic effects of three chemotherapy schemes in the treatment of non- small cell lung cancer (NSCLC).
目的探讨晚期非小细胞肺癌（NSCLC）不同化疗方案的临床疗效和经济学效果。
Objective To evaluate routine mediastinoscopy in detecting mediastinal lymph nodes status in patients with peripheral T1N0M0 non-small cell lung cancer (NSCLC).
目的探讨常规应用纵隔镜检查周围型T1N0M0非小细胞肺癌纵隔淋巴结转移情况。
Objective to investigate the expression of WWOX protein in non-small cell lung cancer (NSCLC), and to analyse its correlation with the clinicopathological features of NSCLC.
目的观察非小细胞肺癌中包含氧化还原酶的ww域(WWOX)蛋白的表达，探讨其与临床病理参数的关系。
KRAS mutation frequency in tumor tissue, can be predicted non-small cell lung cancer molecular targeted therapy efficacy and prognosis, and molecular inhibitors of RAS genes is still in its infancy.
KRAS基因突变在恶性肿瘤组织中频发，可预测非小细胞肺癌分子靶向治疗的疗效和预后，针对RAS基因的分子抑制剂研究仍处于初级阶段。
Objective:To investigate the efficacy of treating taxol plus carboplatin in the treatment of non-small cell lung cancer.
目的：探讨泰素加卡铂联合化疗方案对非小细胞肺癌的疗效。
Medical oncologists are faced with multiple factors to consider when staging a patient with suspected or confirmed non-small cell lung cancer (NSCLC).
肿瘤病学家在对可疑或确诊的非小细胞肺癌患者进行分期时要面临多方面因素的考量。
PURPOSE: To determine the epidemiology, pathology and patterns of care for patients with non-small cell lung cancer (NSCLC) in the United States.
目的：为了测定美国非小细胞肺癌患者的流行病学、病理学和治疗模式。
Lung cancer is responsible for more deaths than any other cancer, with only 15% of patients reaching 5-year survival, and non-small cell lung cancer accounts for 75% of all lung cancer.
肺癌死亡率较其他肿瘤要高，只有15%的病人能达到五年存活期，而且非小细胞肺癌占所有肺部肿瘤的75%。
BACKGROUND: The aim of this study was to identify risk factors associated with survival after pneumonectomy for non-small cell lung cancer.
背景：该研究的目的是鉴别非小细胞肺癌患者全肺切除术治疗后与生存率相关的危险因子。
Objective To investigate the expression of osteopontin (OPN) in non-small cell lung cancer (NSCLC).
目的研究骨桥蛋白(OPN)在非小细胞肺癌(NSCLC)中的表达。
Objective To discuss the diagnostic value of detecting sulfate glycosaminoglycan fragments (SGF) in non-small cell lung cancer (NSCLC).
目的探讨血清硫酸粘多糖片段（SGF）检测在非小细胞肺癌（NSCLC）的诊断价值。
Objective to investigate the proliferation and apoptosis effect of Parthenolide on human non-small cell lung cancer A549 cells in Vitro.
目的研究小白菊内酯在体外对人非小细胞肺癌a 549细胞增殖及凋亡的作用。
Objective: To evaluate the efficiency and adverse reactions of three-dimensional conformal radiotherapy for non-small cell lung cancer.
目的：评价立体适形放射治疗非小细胞肺癌的近期疗效和不良反应。
To investigate the expression and activation of mitogen-activated protein kinases in non-small cell lung cancer and its clinical significance.
目的：探讨丝裂原活化蛋白激酶在非小细胞肺癌中的表达及其临床意义。
Pneumonectomy for non-small cell lung cancer carries an acceptable operative mortality and provides an important survival benefit.
因非小细胞肺癌而接受全肺切除术有可接受的手术死亡率并且能提供重要的生存益处。
Objective: To investigate the levels and clinical value of tissue polypeptide specific antigen (TPS) in serum of patients with non-small cell lung cancer (NSCLC).
目的：探讨血清tps(组织多肽特异性抗原)水平与非小细胞肺癌(NSCLC)患者生物学特征的相关性及其临床应用价值。
Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.
中国的非小细胞肺癌病人中吉非替尼敏感的表皮生长因子受体酪氨酸激酶区域的突变。
Objective: To study the effect of Shenyi capsule on patients with non-small cell lung cancer (NSCLC).
目的观察参一胶囊对非小细胞肺癌的辅助治疗作用。
Objective To study the clinical effect of dose regulation of Body-Gamma Knife radiotherapy in treating local advanced non-small cell lung cancer (NSCLS).
目的在等效生物学剂量的原则下，观察局部晚期非小细胞肺癌体部伽玛刀治疗剂量调整后的疗效、生存情况。
Objective to observe the efficacy and toxicity of gemcitabine of different dosages and methods plus carboplatin in patients with advanced non-small-cell lung cancer (NSCLC).
目的观察不同剂量、用法的吉西他滨联合伯尔定治疗晚期非小细胞肺癌的疗效和不良反应。
Objective to study the mutation patterns of epithelial growth factor receptor (EGFR) exon 18, 19 and 21 in Chinese non-small-cell lung cancers (NSCLC).
目的探讨中国人非小细胞肺癌表皮生长因子受体(EGFR)第18、19、21外显子基因突变状态。
Objective to study the mutation patterns of epithelial growth factor receptor (EGFR) exon 18, 19 and 21 in Chinese non-small-cell lung cancers (NSCLC).
目的探讨中国人非小细胞肺癌表皮生长因子受体(EGFR)第18、19、21外显子基因突变状态。
应用推荐